pageInfo({
    time : "1261410072680"
  
	    , page : null
	  
	    , url : null
	  
	    , instrument : null
	  
	    , article : {
	        storyId : "USLA49330220090712"
	        , headline : "Study may prompt rethink on schizophrenia drugs"
	        , keywords : "[Pharmaceuticals - diversified, Pharmaceuticals (sub-industry), Switzerland, Western Europe, Europe, Pharmaceuticals - generic and speciality, United Kingdom, United States of America, Health and medicine, Living and lifestyle, Healthcare, Pharmaceuticals and biotechnology, Central and Eastern Europe, Economic news, EC, business/financial pages]"
	        , tickers : "[AZN.L, gb;LELZ, JNJ.N, LLY.N, mx;JNJ, mx;LLY, us;AZN, us;AZNC, us;AZND, us;JNJ, gb;LEL, gb;AZNX, ch;JNJ, ch;LLY, ch;NOV, de;JNJ, us;LLY, de;JNJF, de;JNJS, de;LLY, gb;AZN, gb;AZND, NOVN.VX]"
	    }
	    , channel : {
	        id : "1113"
	        , name : "rbssHealthcareNews"
	        , title : "Healthcare"
	    }})